Bone changes in alcoholic liver disease

World Journal of Hepatology

Volumn 7, Issue 9, 2015, Pages 1258-1264

  González Reimers, Emilio ^a   Quintero Platt, Geraldine ^a   Rodríguez Rodríguez, Eva ^a   Martínez Riera, Antonio ^a   Alvisa Negrín, Julio ^a   Santolaria Fernández, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Alcoholism; Bone fractures; Liver disease; Osteoporosis; Vitamin D

Indexed keywords

EID: 84929713586     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i9.1258     Document Type: Review

References (71)

1. Oppenheim WL. The "battered alcoholic syndrome". J Trauma 1977; 17: 850-856 [PMID: 915961 DOI: 10.1097/00005373-197711000-00006]
2. Saville PD. Changes in bone mass with age and alcoholism. J Bone Joint Surg Am 1965; 47: 492-499 [PMID: 14275168]
3. Snell W. The chronic alcoholic and his fractures. J Bone Joint Surg (Am) 1971; 53-A: 1655
4. Israel Y, Orrego H, Holt S, Macdonald DW, Meema HE. Identification of alcohol abuse: thoracic fractures on routine chest X-rays as indicators of alcoholism. Alcohol Clin Exp Res 1980; 4: 420-422 [PMID: 7004243 DOI: 10.1111/j.1530-0277.1980. tb04842.x]
5. Arlot ME, Bonjean M, Chavassieux PM, Meunier PJ. Bone histology in adults with aseptic necrosis. Histomorphometric evaluation of iliac biopsies in seventy-seven patients. J Bone Joint Surg Am 1983; 65: 1319-1327 [PMID: 6361038]
6. Chakkalakal DA. Alcohol-induced bone loss and deficient bone repair. Alcohol Clin Exp Res 2005; 29: 2077-2090 [PMID: 16385177 DOI: 10.1097/01.alc.0000192039.21305.55]
7. Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S. Ethanol reduces bone formation and may cause osteoporosis. Am J Med 1989; 86: 282-288 [PMID: 2784031 DOI: 10.1016/0002-9343(89)90297-0]
8. Gonzalez-Calvín JL, Garcia-Sanchez A, Bellot V, Muñoz-Torres M, Raya-Alvarez E, Salvatierra-Rios D. Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol 1993; 28: 571-579 [PMID: 8274181]
9. Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol 2013; 228: 1149-1153 [PMID: 23139068 DOI: 10.1002/jcp.24278]
10. Santori C, Ceccanti M, Diacinti D, Attilia ML, Toppo L, D' Erasmo E, Romagnoli E, Mascia ML, Cipriani C, Prastaro A, Carnevale V, Minisola S. Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol. J Endocrinol Invest 2008; 31: 321-326 [PMID: 18475050]
11. Giuliani N, Girasole G, Vescovi PP, Passeri G, Pedrazzoni M. Ethanol and acetaldehyde inhibit the formation of early osteoblast progenitors in murine and human bone marrow cultures. Alcohol Clin Exp Res 1999; 23: 381-385 [PMID: 10069572 DOI: 10.1111/j.1530-0277.1999.tb04126.x]
12. Torricelli P, Fini M, Giavaresi G, Borsari V, Rimondini L, Rimondini R, Carrassi A, Giardino R. Intermittent exposure to ethanol vapor affects osteoblast behaviour more severely than estrogen deficiency does in vitro study on rat osteoblasts. Toxicology 2007; 237: 168-176 [PMID: 17590496 DOI: 10.1016/j. tox.2007.05.010]
13. Lau JR, Farley R, Fitzsimmons AK. An in vitro investigation of effects of ethanol on bone formation and bone resorption. Orthopaedic Research Society 1985; 9: 278-279
14. Marrone JA, Maddalozzo GF, Branscum AJ, Hardin K, Cialdella-Kam L, Philbrick KA, Breggia AC, Rosen CJ, Turner RT, Iwaniec UT. Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal women. Menopause 2012; 19: 974-979 [PMID: 22922514 DOI: 10.1097/gme.0b013e31824ac071]
15. Sommer I, Erkkilä AT, Järvinen R, Mursu J, Sirola J, Jurvelin JS, Kröger H, Tuppurainen M. Alcohol consumption and bone mineral density in elderly women. Public Health Nutr 2013; 16: 704-712 [PMID: 22800300 DOI: 10.1017/S136898001200331X]
16. Berg KM, Kunins HV, Jackson JL, Nahvi S, Chaudhry A, Harris KA, Malik R, Arnsten JH. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med 2008; 121: 406-418 [PMID: 18456037 DOI: 10.1016/j.amjmed.2007.12.012]
17. Chen JR, Lazarenko OP, Shankar K, Blackburn ML, Lumpkin CK, Badger TM, Ronis MJ. Inhibition of NADPH oxidases prevents chronic ethanol-induced bone loss in female rats. J Pharmacol Exp Ther 2011; 336: 734-742 [PMID: 21098090 DOI: 10.1124/jpet.110.175091]
18. Lee YS, Choi EM. Apocynin stimulates osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells. Cell Immunol 2011; 270: 224-229 [PMID: 21683946 DOI: 10.1016/j.cellimm.2011.05.011]
19. Choi EM, Lee YS. Protective effect of apocynin on antimycin A-induced cell damage in osteoblastic MC3T3-E1 cells. J Appl Toxicol 2012; 32: 714-721 [PMID: 21538410 DOI: 10.1002/jat.1689]
20. Chen Y, Gao H, Yin Q, Chen L, Dong P, Zhang X, Kang J. ER stress activating ATF4/CHOP-TNF-α signaling pathway contributes to alcohol-induced disruption of osteogenic lineage of multipotential mesenchymal stem cell. Cell Physiol Biochem 2013; 32: 743-754 [PMID: 24080827 DOI: 10.1159/000354476]
21. Maurel DB, Pallu S, Jaffré C, Fazzalari NL, Boisseau N, Uzbekov R, Benhamou CL, Rochefort GY. Osteocyte apoptosis and lipid infiltration as mechanisms of alcohol-induced bone loss. Alcohol Alcohol 2012; 47: 413-422 [PMID: 22596044 DOI: 10.1093/alcalc/ags057]
22. Lindholm J, Steiniche T, Rasmussen E, Thamsborg G, Nielsen IO, Brockstedt-Rasmussen H, Storm T, Hyldstrup L, Schou C. Bone disorder in men with chronic alcoholism: a reversible disease? J Clin Endocrinol Metab 1991; 73: 118-124 [PMID: 2045462 DOI: 10.1210/jcem-73-1-118]
23. Peris P, Parés A, Guañabens N, Del Río L, Pons F, Martínez de Osaba MJ, Monegal A, Caballería J, Rodés J, Muñoz-Gómez J. Bone mass improves in alcoholics after 2 years of abstinence. J Bone Miner Res 1994; 9: 1607-1612 [PMID: 7817807]
24. Alvisa-Negrín J, González-Reimers E, Santolaria-Fernández F, García-Valdecasas-Campelo E, Valls MR, Pelazas-González R, Durán-Castellón MC, de Los Angeles Gómez-Rodríguez M. Osteopenia in alcoholics: effect of alcohol abstinence. Alcohol Alcohol 2009; 44: 468-475 [PMID: 19535494 DOI: 10.1093/alcalc/agp038]
25. Turner RT, Aloia RC, Segel LD, Hannon KS, Bell NH. Chronic alcohol treatment results in disturbed vitamin D metabolism and skeletal abnormalities in rats. Alcohol Clin Exp Res 1988; 12: 159-162 [PMID: 3279849 DOI: 10.1111/j.1530-0277.1988.tb00152. x]
26. Sampson HW, Spears H. Osteopenia due to chronic alcohol consumption by young actively growing rats is not completely reversible. Alcohol Clin Exp Res 1999; 23: 324-327 [PMID: 10069563 DOI: 10.1111/j.1530-0277.1999.tb04117.x]
27. Santolaria F, González-Reimers E, Pérez-Manzano JL, Milena A, Gómez-Rodríguez MA, González-Díaz A, de la Vega MJ, Martínez-Riera A. Osteopenia assessed by body composition analysis is related to malnutrition in alcoholic patients. Alcohol 2000; 22: 147-157 [PMID: 11163122 DOI: 10.1016/S0741-8329(00)00115-4]
28. Smith J. The effect of alcohol on the ascorbic acid and cholesterol of the rat. J Clin Endoc 1951; 11: 792-797
29. Badrick E, Bobak M, Britton A, Kirschbaum C, Marmot M, Kumari M. The relationship between alcohol consumption and cortisol secretion in an aging cohort. J Clin Endocrinol Metab 2008; 93: 750-757 [PMID: 18073316 DOI: 10.1210/jc.2007-0737]
30. Ceroni L, Cota D, Pasquali R. [Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis]. Minerva Endocrinol 2000; 25: 47-54 [PMID: 11189791]
31. Kapcala LP. Alcohol-induced pseudo-Cushing's syndrome mimicking Cushing's disease in a patient with an adrenal mass. Am J Med 1987; 82: 849-856 [PMID: 3565439 DOI: 10.1016/0002-9343(87)90028-3]
32. Lamberts SW, Klijn JG, de Jong FH, Birkenhäger JC. Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease. JAMA 1979; 242: 1640-1643 [PMID: 39183 DOI: 10.1001/jama.242.15.1640]
33. Kirkman S, Nelson DH. Alcohol-induced pseudo-Cushing's disease: a study of prevalence with review of the literature. Metabolism 1988; 37: 390-394 [PMID: 2833680 DOI: 10.1016/0026-0495(88)90141-2]
34. Alwani RA, Schmit Jongbloed LW, de Jong FH, van der Lely AJ, de Herder WW, Feelders RA. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests. Eur J Endocrinol 2014; 170: 477-486 [PMID: 24394725 DOI: 10.1530/EJE-13-0702]
35. Lloyd SA, Lang CH, Zhang Y, Paul EM, Laufenberg LJ, Lewis GS, Donahue HJ. Interdependence of muscle atrophy and bone loss induced by mechanical unloading. J Bone Miner Res 2014; 29: 1118-1130 [PMID: 24127218 DOI: 10.1002/jbmr.2113]
36. Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, Esteghamati A, Abdollahi A, Mazloumi M. Disturbances of parathyroid hormone-vitamin D axis in non-cholestatic chronic liver disease: a cross-sectional study. Hepatol Int 2010; 4: 634-640 [PMID: 21063488 DOI: 10.1007/s12072-010-9194-2]
37. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5: 513-520 [PMID: 17222588 DOI: 10.1016/j.cgh.2006.10.015]
38. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R, Stähelin HB, Dick W. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001; 33: 19-24 [PMID: 11352397]
39. Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev 2013; 34: 33-83 [PMID: 23169676 DOI: 10.1210/er.2012-1012]
40. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol Aspects Med 2008; 29: 407-414 [PMID: 18727936 DOI: 10.1016/j.mam.2008.07.002]
41. Bannister P, Losowsky MS. Ethanol and hypogonadism. Alcohol Alcohol 1987; 22: 213-217 [PMID: 3304308]
42. Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest 2006; 116: 1202-1209 [PMID: 16670761 DOI: 10.1172/JCI28551]
43. Kramer I, Halleux C, Keller H, Pegurri M, Gooi JH, Weber PB, Feng JQ, Bonewald LF, Kneissel M. Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Mol Cell Biol 2010; 30: 3071-3085 [PMID: 20404086 DOI: 10.1128/MCB.01428-09]
44. Chen Y, Chen L, Yin Q, Gao H, Dong P, Zhang X, Kang J. Reciprocal interferences of TNF-α and Wnt1/ß-catenin signaling axes shift bone marrow-derived stem cells towards osteoblast lineage after ethanol exposure. Cell Physiol Biochem 2013; 32: 755-765 [PMID: 24080828 DOI: 10.1159/000354477]
45. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005; 280: 19883-19887 [PMID: 15778503 DOI: 10.1074/jbc.M413274200]
46. Sheng Z, Tong D, Ou Y, Zhang H, Zhang Z, Li S, Zhou J, Zhang J, Liao E. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women. Clin Endocrinol (Oxf) 2012; 76: 797-801 [PMID: 22151063 DOI: 10.1111/j.1365-2265.2011.04315.x]
47. González-Reimers E, Martín-González C, de la Vega-Prieto MJ, Pelazas-González R, Fernández-Rodríguez C, López-Prieto J, Alvisa-Negrín J, Santolaria-Fernández F. Serum sclerostin in alcoholics: a pilot study. Alcohol Alcohol 2013; 48: 278-282 [PMID: 23296214 DOI: 10.1093/alcalc/ags136]
48. Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 2007; 9 Suppl 1: S1 [PMID: 17634140 DOI: 10.1186/ar2165]
49. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319 [PMID: 9108485 DOI: 10.1016/S0092-8674(00)80209-3]
50. Takahashi N, Maeda K, Ishihara A, Uehara S, Kobayashi Y. Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals. Front Biosci (Landmark Ed) 2011; 16: 21-30 [PMID: 21196156 DOI: 10.2741/3673]
51. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999; 25: 255-259 [PMID: 10495128]
52. Fukui H. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure. Alcohol Clin Exp Res 2005; 29: 172S-179S [PMID: 16344605 DOI: 10.1097/01.alc.0000189278.30237.e9]
53. Nakatani Y, Fukui H, Kitazawa T, Fujimoto M, Yamao J, Uemura M. Effect of alcohol on the secretion of tumor necrosis factor-alpha by macrophages in the presence of rat serum. Alcohol Clin Exp Res 2002; 26: 81S-85S [PMID: 12198381 DOI: 10.1097/01. ALC.0000026982.94557.1A]
54. Mercer KE, Sims CR, Yang CS, Wynne RA, Moutos C, Hogue WR, Lumpkin CK, Suva LJ, Chen JR, Badger TM, Ronis MJ. Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice. Alcohol Clin Exp Res 2014; 38: 672-682 [PMID: 24256560 DOI: 10.1111/acer.12305]
55. Turner RT. Skeletal response to alcohol. Alcohol Clin Exp Res 2000; 24: 1693-1701 [PMID: 11104117 DOI: 10.1111/j.1530-0277.2000. tb01971.x]
56. García-Valdecasas-Campelo E, González-Reimers E, Santolaria-Fernández F, De la Vega-Prieto MJ, Milena-Abril A, Sánchez-Pérez MJ, Martínez-Riera A, Gómez-Rodríguez Mde L. Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease. Alcohol Alcohol 2006; 41: 261-266 [PMID: 16476762 DOI: 10.1093/alcalc/agl004]
57. Bunout D. Nutritional and metabolic effects of alcoholism: their relationship with alcoholic liver disease. Nutrition 1999; 15: 583-589 [PMID: 10422091 DOI: 10.1016/S0899-9007(99)00090-8]
58. González-Reimers E, Durán-Castellón MC, Martín-Olivera R, López-Lirola A, Santolaria-Fernández F, De la Vega-Prieto MJ, Pérez-Ramírez A, García-Valdecasas Campelo E. Effect of zinc supplementation on ethanol-mediated bone alterations. Food Chem Toxicol 2005; 43: 1497-1505 [PMID: 15964119 DOI: 10.1016/j.fct.2005.04.003]
59. McClain CJ, Su LC. Zinc deficiency in the alcoholic: a review. Alcohol Clin Exp Res 1983; 7: 5-10 [PMID: 6342450 DOI: 10.1111/j.1530-0277.1983.tb05402.x]
60. Yamaguchi M. Role of nutritional zinc in the prevention of osteoporosis. Mol Cell Biochem 2010; 338: 241-254 [PMID: 20035439 DOI: 10.1007/s11010-009-0358-0]
61. Pitts TO, Van Thiel DH. Disorders of divalent ions and vitamin D metabolism in chronic alcoholism. Recent Dev Alcohol 1986; 4: 357-377 [PMID: 3754648]
62. Laitinen K, Välimäki M. Alcohol and bone. Calcif Tissue Int 1991; 49 Suppl: S70-S73 [PMID: 1933604 DOI: 10.1007/BF02555094]
63. Chen H, Hayakawa D, Emura S, Tamada A, Jamali M, Ozawa Y, Taguchi H, Yano R, Ohtake N, Shoumura S. Effects of long-term treatment with ethanol on the ultrastructure of the golden hamster parathyroid gland. Histol Histopathol 1999; 14: 343-349 [PMID: 10212795]
64. Kalbfleisch JM, Lindeman RD, Ginn HE, Smith WO. Effects of ethanol administration on urinary excretion of magnesium and other electrolytes in alcoholic and normal subjects. J Clin Invest 1963; 42: 1471-1475 [PMID: 14060991 DOI: 10.1172/JCI104831]
65. Mercer KE, Wynne RA, Lazarenko OP, Lumpkin CK, Hogue WR, Suva LJ, Chen JR, Mason AZ, Badger TM, Ronis MJ. Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther 2012; 343: 401-412 [PMID: 22892342 DOI: 10.1124/jpet.112.197038]
66. Wezeman FH, Juknelis D, Himes R, Callaci JJ. Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats. Bone 2007; 41: 639-645 [PMID: 17643361 DOI: 10.1016/j.bone.2007.06.002]
67. Drake MT, Clarke BL, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008; 83: 1032-1045 [PMID: 18775204 DOI: 10.4065/83.9.1032]
68. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev 2008; (1): CD001155 [PMID: 18253985 DOI: 10.1002/14651858.CD001155.pub2]
69. Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C. Bispho-sphonates for osteoporosis in primary biliary cirrhosis. Cochrane Database Syst Rev 2011; (12): CD009144 [PMID: 22161446 DOI: 10.1002/14651858.CD009144.pub2]
70. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Glüer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999; 282: 637-645 [PMID: 10517716 DOI: 10.1001/jama.282.7.637]
71. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009; 361: 756-765 [PMID: 19671655 DOI: 10.1056/NEJMoa0809493]